SNY FDA calendar & decision history Sanofi · no upcoming catalyst on file · 7 past FDA decisions
FDA decision history (7) Apr 22, 2026✓ Approved DUPIXENT (dupilumab) - (LIBERT Feb 24, 2026✓ Approved FDA decision Dec 28, 2025✕ CRL FDA decision Aug 29, 2025✓ Approved FDA decision Jun 2, 2025✓ Approved FDA decision Apr 18, 2025✓ Approved FDA decision Mar 28, 2025✓ Approved FDA decision See the full 2026 PDUFA calendar → This page aggregates SNY's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent service; "FDA", "PDUFA", and all company, drug, and ticker names are used descriptively and remain the property of their owners. Informational and educational only — not investment advice. Data and historical statistics only; no trade recommendations and no individual-drug approval probabilities. Verify every date and outcome against primary FDA / SEC / company filings. © 2026 pdufa.bio